Electrome Launches the ActiPatch® Platform for Non-Opioid Pain Care

Electrome Corporation today launched PAINKILLER, the consumer facing brand of its bioelectric pain management platform. PAINKILLER pairs an FDA cleared pulsed shortwave therapy wearable with a software platform that captures adherence and outcomes, supports clinician workflows, and reaches patients across clinical, retail, and direct to consumer channels.

Launch scope

The launch establishes the consumer e commerce surface, the initial cohort of provider partners, and the first wave of retailer relationships under the PAINKILLER brand. Affiliate and creator partnerships open in a subsequent phase.

About PAINKILLER

PAINKILLER is a wearable bioelectric platform for non opioid pain management. The underlying device is FDA cleared for musculoskeletal pain and edema. The platform supports patients, clinicians, and partners with a single data backbone.

Forward looking statements

This release includes forward looking statements regarding launch metrics and partner adoption. Actual results may differ materially.

About the launch

The PAINKILLER launch is structured around three coordinated channels. A direct to consumer channel anchored by the PAINKILLER store. A provider channel that supports clinicians offering the FDA cleared device as part of a multimodal chronic pain plan. A retailer channel that brings the wearable bioelectric option onto retail pain category shelves under partner agreements. The launch sequence is designed to ensure that patient experience, clinical safety messaging, and supply continuity are coordinated across channels rather than fragmented.

About PAINKILLER

PAINKILLER is the consumer brand of the FDA cleared pulsed shortwave therapy program operated by Electrome Corporation. The program is built on a wearable bioelectric device with peer reviewed mechanism literature and a clinical evidence base in chronic musculoskeletal pain. The platform behind the brand captures usage and patient reported outcomes, supports the relationship between patient and clinician where one is in the loop, and operates inside the regulatory boundaries of the cleared device.

About distribution

PAINKILLER is available through the Electrome operated direct to consumer shop and through a coordinated network of provider, retailer, and affiliate channels. Each channel reads from the same underlying platform, so the patient experience after the purchase, including adherence support and outcomes capture, is consistent regardless of how the patient first reached the product.